Table 1.
Experimental models, melatonin concentrations and markers used in EMT studies.
Tumor | Cell Lines | In Vivo | [Mel] | Upregulated Genes | Downregulated Genes | References |
---|---|---|---|---|---|---|
Gastric cancer | AG5, MKN45 | 0.1 μM–2 mM | E-cadherin | MMP2, MMP9, NF-κB, Snail | [115] | |
Gastric cancer | MGC80-3, SGC790 | 0.1–1.5 mM | E-cadherin | Snail, Slug, Wnt/β-catenin, NF-κB | [116] | |
Gastric cancer | MGC80-3 | In vivo lung metastasis | 100 mg/Kg/day | E-cadherin | MMP2, MMP9, NF-κB, Snail, Slug, Fibronectin | [122] |
Ovarian cancer | SK-OV-3 | 3.4 mM | ZEB1, ZEB2, Snail, Vimentin | [118] | ||
Ovarian cancer | SK-OV-3 | Tumor-bearing mouse model | 200 μg/100 g/day | Akt, β-catenin, Slug | [119] | |
Bladder cancer | UC3 | 1 μM | E-cadherin | N-cadherin, Fibronectin, Snail, Slug | [117] | |
Oral cancer | SCC25, SCC9, Tca8113, Cal27, FaDu | 1 mM | Akt, Snail, Vimentin | [120] | ||
Breast cancer | MCF-7, MDA-MB-231 | 1 nM | E-cadherin | Snail | [121] | |
Breast cancer | MCF-7 | 1 nM | Twist1, Slug, Akt | [129] | ||
Osteosarcoma | MG-63 | 200 nM | E-cadherin | N-cadherin, Snail, MMP-9 | [123] | |
Colorrectal cancer | HCT-15 SW620 | 1–2 mM | E-cadherin | Snail | [124] | |
Gallbladder cancer | GBC-SD | 0.1–2 mM | E-cadherin | N-cadherin, Snail, Vimentin | [125] | |
Non-small cell lung cancer | H1299 | 0.1 mM | Snail, Twist1 | [126] | ||
Lung cancer | A549, CL1-5 | 1 mM | Twist1 | [127] | ||
Lung cancer | CL1-5 | 1 mM | Slug, Twist1, β-catenin | [128] |